The Wearable Artificial Endocrine Pancreas with a Needle‐ Type Glucose Sensor: Perfect Glycemic Control in Ambulatory Diabetics

We have succeeded in miniaturizing a glucose monitoring system into a needle type which preserves the characteristics suitable to apply in a wearable closed‐loop control system. The wearable artificial endocrine pancreas (12 times 15 times 6 cm, 400 g) consists of the sensor, a microcomputer system which calculates insulin and glucagon infusion rates and a 2‐syringe driving system.

[1]  Y. Yamasaki,et al.  Rapid Publication Perfect Normalization of Glucagon Responses to Intravenous Arginine in Human Diabetes Mellitus With the Artificial Beta-Cell , 1980 .

[2]  Y. Yamasaki,et al.  WEARABLE ARTIFICIAL ENDOCRINE PANCREAS WITH NEEDLE-TYPE GLUCOSE SENSOR , 1982, The Lancet.

[3]  R. Kawamori,et al.  Normalization of the Paradoxic Secretion of Glucagon in Diabetics Who Were Controlled by the Artificial Beta Cell , 1979, Diabetes.

[4]  S. Woodward.  How Fibroblasts and Giant Cells Encapsulate Implants: Considerations in Design of Glucose Sensors , 1982, Diabetes Care.

[5]  R. Kawamori,et al.  The development of an artificial beta cell system and its validation in depancreatized dogs: the physiological restoration of blood glucose homeostasis. , 1979, Medical progress through technology.

[6]  A H Clemens,et al.  The artificial beta cell--a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). , 1974, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[7]  Y. Yamasaki,et al.  Perfect Normalization of Excessive Glucagon Responses to Intravenous Arginine in Human Diabetes Mellitus With the Artificial Beta-Cell , 1980, Diabetes.

[8]  H. D. V. Liew.  Oxygen and carbon dioxide tensions in tissue and blood of normal and acidotic rats. , 1968 .

[9]  Y. Yamasaki,et al.  Importance of insulin secretion based on the rate of change in blood glucose concentration in glucose tolerance, assessed by the artificial beta cell. , 1978, Acta endocrinologica.